Overview
Shoals Technologies Group is the leading manufacturer of balance of systems solutions worldwide. Consistently providing customers with innovative designs and superior quality products, the company has seen exponential growth since its founding in 1996. With over 35 GW of BOS products deployed globally, Shoals maintains a diverse portfolio of solar balance of systems products, including combiner/re-combiner boxes, disconnect boxes, custom harnessing solutions, junction boxes, wire, in-line fuses, and racking and monitoring solutions.
Basic Stats
The share price of Shoals Technologies Group, Inc. as of September 5, 2025 is $7.16 / share. This is an increase of 9.91% from the prior week. The market cap (or net worth) of Shoals Technologies Group, Inc. as of September 5, 2025 is $1,196.58 MM.
The Factor Analysis chart (below right) shows a view of Shoals Technologies Group, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 1,196.58 MM |
| EV | 1,323.64 MM |
| Shares Out. | 167.35 MM |
| Earnings Date | |
| EPS (TTM) | 0.13 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | 0.37 |
| Short Shares Avail. | 2.30 MM |
| Short Interest | 20.22 MM |
| Short Float | 13.22 % |
| Days to Cover | 2.94 days |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 30.47 % |
| Volatility (1 yr) | 0.89 |
| Beta | 0.74 |
| Sharpe Ratio (1 yr) | 0.30 |
| Sortino Ratio (1 yr) | 0.51 |
| PE Ratio | 56.65 |
| Price/Book | 2.08 |
| Price/TBV | 2.56 |
| Book/Market | 0.48 |
| EBIT/EV | 0.03 |
| EBIT(3yr avg)/EV | 0.06 |
| ROA | 0.03 |
| ROE | 0.04 |
| ROIC | 0.03 |
| CROIC | 0.00 |
| OCROIC | 0.04 |
| Implied Volatility | 74.81 % |
| Put/Call OI Ratio | 0.34 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Shoals Technologies Group, Inc. is $7.33. The forecasts range from a low of $4.04 to a high of $11.55. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Shoals Technologies Group, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-01-20 | Cowen & Co. | Outperform | Maintains | |
| 2023-01-17 | Credit Suisse | Outperform | Maintains | |
| 2022-11-16 | Barclays | Equal-Weight | Maintains | |
| 2022-11-15 | Piper Sandler | Neutral | Maintains | |
| 2022-11-15 | Northland Capital Markets | Market Perform | Outperform | Upgrade |
| 2022-11-15 | JP Morgan | Overweight | Maintains | |
| 2022-11-15 | Goldman Sachs | Sell | Maintains | |
| 2022-10-20 | JP Morgan | Overweight | Maintains | |
| 2022-09-22 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-09-16 | Cowen & Co. | Market Perform | Outperform | Upgrade |
| 2022-09-09 | Guggenheim | Buy | Neutral | Downgrade |
| 2022-09-08 | Goldman Sachs | Buy | Sell | Downgrade |
| 2022-08-18 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-08-16 | Truist Securities | Buy | Maintains | |
| 2022-08-16 | Barclays | Equal-Weight | Maintains | |
| 2022-08-08 | JP Morgan | Overweight | Maintains | |
| 2022-08-05 | Barclays | Equal-Weight | Initiate | |
| 2022-07-25 | Credit Suisse | Outperform | Maintains | |
| 2022-07-20 | JP Morgan | Overweight | Maintains | |
| 2022-07-19 | Piper Sandler | Neutral | Maintains | |
| 2022-07-19 | Northland Capital Markets | Outperform | Market Perform | Downgrade |
| 2022-06-21 | Goldman Sachs | Buy | Maintains | |
| 2022-06-13 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-06-09 | Truist Securities | Hold | Buy | Upgrade |
| 2022-05-18 | Truist Securities | Hold | Maintains | |
| 2022-05-18 | Credit Suisse | Outperform | Maintains | |
| 2022-05-17 | Guggenheim | Buy | Maintains | |
| 2022-05-10 | Northland Capital Markets | Outperform | Initiate | |
| 2022-04-19 | JP Morgan | Overweight | Maintains | |
| 2022-04-08 | Piper Sandler | Overweight | Neutral | Downgrade |
| 2022-03-22 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-03-11 | Piper Sandler | Overweight | Maintains | |
| 2022-03-11 | Guggenheim | Neutral | Buy | Upgrade |
| 2022-01-24 | Truist Securities | Hold | Maintains | |
| 2022-01-13 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-11-10 | Barclays | Equal-Weight | Maintains | |
| 2021-10-20 | Guggenheim | Buy | Neutral | Downgrade |
| 2021-10-15 | Truist Securities | Hold | Initiate | |
| 2021-08-19 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-06-30 | Piper Sandler | Overweight | Initiate | |
| 2021-05-26 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-05-24 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2021-05-20 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2021-04-22 | Barclays | Overweight | Equal-Weight | Downgrade |
| 2021-03-23 | Johnson Rice | Buy | Initiate | |
| 2021-03-11 | Roth Capital | Buy | Initiate | |
| 2021-03-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2021-02-22 | UBS | Buy | Initiate | |
| 2021-02-22 | Morgan Stanley | Equal-Weight | Initiate | |
| 2021-02-22 | Guggenheim | Buy | Initiate | |
| 2021-02-22 | Credit Suisse | Neutral | Initiate | |
| 2021-02-22 | Barclays | Overweight | Initiate | |
| 2023-01-25 | Cantor Fitzgerald | Neutral | Initiate | |
| 2023-01-10 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-02-27 | Truist Securities | Buy | Maintains | |
| 2023-03-01 | Northland Capital Markets | Outperform | Market Perform | Downgrade |
| 2023-03-06 | Credit Suisse | Outperform | Reiterate | |
| 2023-03-10 | Citigroup | Buy | Initiate | |
| 2023-03-30 | Goldman Sachs | Sell | Neutral | Upgrade |
| 2023-04-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-05-02 | Barclays | Equal-Weight | Underweight | Downgrade |
| 2023-05-10 | Goldman Sachs | Neutral | Maintains | |
| 2023-05-09 | Oppenheimer | Outperform | Maintains | |
| 2023-05-09 | Goldman Sachs | Neutral | Maintains | |
| 2023-05-09 | Northland Capital Markets | Market Perform | Outperform | Upgrade |
| 2023-05-09 | Guggenheim | Neutral | Buy | Upgrade |
| 2023-05-09 | Truist Securities | Buy | Maintains | |
| 2023-05-09 | Cantor Fitzgerald | Neutral | Maintains | |
| 2023-10-06 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2024-03-05 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-19 | Mizuho | Buy | Buy | Maintains |
| 2023-09-12 | Truist Securities | Buy | Buy | Maintains |
| 2023-08-04 | Barclays | Underweight | Underweight | Maintains |
| 2023-10-04 | Truist Securities | Buy | Buy | Maintains |
| 2023-07-17 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-09-05 | Cantor Fitzgerald | Neutral | Overweight | Upgrade |
| 2023-11-09 | Truist Securities | Buy | Buy | Maintains |
| 2023-12-08 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-20 | Exane BNP Paribas | Outperform | Initiate | |
| 2023-10-19 | JP Morgan | Overweight | Overweight | Maintains |
| 2023-10-05 | Northland Capital Markets | Outperform | Market Perform | Downgrade |
| 2023-08-02 | Oppenheimer | Outperform | Outperform | Reiterate |
| 2023-09-06 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-10-17 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-08 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2023-10-18 | Citigroup | Buy | Buy | Maintains |
| 2023-10-11 | Goldman Sachs | Neutral | Buy | Upgrade |
| 2023-11-21 | Mizuho | Buy | Initiate | |
| 2024-04-11 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-03-01 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-03-01 | UBS | Buy | Buy | Maintains |
| 2024-02-14 | RBC Capital | Outperform | Initiate | |
| 2024-01-22 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2024-05-09 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-05-08 | Northland Capital Markets | Market Perform | Underperform | Downgrade |
| 2024-05-08 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-05-08 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-05-08 | TD Cowen | Buy | Buy | Maintains |
| 2024-05-08 | Mizuho | Buy | Buy | Maintains |
| 2024-05-08 | Roth MKM | Buy | Neutral | Downgrade |
| 2024-02-29 | Mizuho | Buy | Buy | Reiterate |
| 2024-02-29 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-02-29 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-02-29 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-02-29 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-02-29 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2024-02-29 | Truist Securities | Buy | Buy | Reiterate |
| 2024-05-07 | Roth MKM | Buy | Buy | Maintains |
| 2024-03-11 | Roth MKM | Buy | Buy | Maintains |
| 2024-03-13 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-01-03 | Mizuho | Buy | Buy | Maintains |
| 2024-07-08 | RBC Capital | Outperform | Outperform | Maintains |
| 2024-07-02 | Citigroup | Buy | Sell | Downgrade |
| 2024-07-16 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-10-10 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-09-06 | Truist Securities | Buy | Buy | Maintains |
| 2024-09-06 | Roth MKM | Neutral | Neutral | Maintains |
| 2024-09-06 | RBC Capital | Outperform | Outperform | Reiterate |
| 2024-08-08 | Northland Capital Markets | Underperform | Underperform | Maintains |
| 2024-08-08 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-23 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-05-09 | Guggenheim | Buy | Buy | Maintains |
| 2024-07-18 | UBS | Buy | Buy | Maintains |
| 2024-07-18 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-09-10 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-11-21 | Guggenheim | Buy | Buy | Maintains |
| 2024-09-17 | Cantor Fitzgerald | Overweight | Overweight | Reiterate |
| 2024-10-03 | Citigroup | Sell | Neutral | Upgrade |
| 2024-09-04 | Jefferies | Hold | Initiate | |
| 2024-10-17 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-11-22 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-11-15 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-24 | Mizuho | Outperform | Outperform | Maintains |
| 2024-08-07 | Truist Securities | Buy | Buy | Reiterate |
| 2024-08-07 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-08-07 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-08-07 | UBS | Buy | Buy | Maintains |
| 2024-08-07 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-01-28 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-11-13 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-13 | TD Cowen | Buy | Buy | Maintains |
| 2025-05-07 | Citigroup | Neutral | Neutral | Maintains |
| 2025-05-07 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-10-14 | Wells Fargo | Equal-Weight | Initiate | |
| 2025-01-16 | Truist Securities | Buy | Buy | Maintains |
| 2024-11-25 | B of A Securities | Buy | Initiate | |
| 2025-01-17 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-01-22 | Goldman Sachs | Buy | Buy | Maintains |
| 2025-02-18 | Wolfe Research | Peer Perform | Initiate | |
| 2025-05-15 | Exane BNP Paribas | Neutral | Underperform | Downgrade |
| 2024-12-17 | Goldman Sachs | Buy | Buy | Maintains |
| 2024-12-17 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2025-02-26 | Roth MKM | Neutral | Neutral | Maintains |
| 2025-02-26 | RBC Capital | Outperform | Outperform | Maintains |
| 2025-02-26 | Goldman Sachs | Buy | Buy | Maintains |
| 2025-02-26 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-02-26 | UBS | Buy | Buy | Maintains |
| 2025-03-12 | Jefferies | Hold | Hold | Maintains |
| 2025-07-18 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2025-06-02 | Mizuho | Outperform | Outperform | Maintains |
| 2025-08-06 | Guggenheim | Buy | Buy | Maintains |
| 2025-08-06 | UBS | Buy | Buy | Maintains |
| 2025-07-07 | Jefferies | Hold | Buy | Upgrade |
